Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
GlobeNewswire
Siren Biotechnology Named Innovator of the Year in 2026 BioTech Breakthrough Awards
Read More
GlobeNewswire
Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board
Read More
Endpoints News
Siren CEO named as a 2026 Endpoints News Women in Biopharma
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Media Coverage
|
Posted on 10.4.23
2023 All-In Summit – A discussion on the future of gene therapy
Read More
Media Coverage
|
Posted on 9.13.23
Webinar – The State of Biotech 2023
Read More
Media Coverage
|
Posted on 8.24.23
Developing universal AAV immuno-gene therapy for oncology
Read More
Media Coverage
|
Posted on 5.18.23
New biotech Siren calls for gene therapy and cancer to ‘get into the weeds together’
Read More
Media Coverage
|
Posted on 5.17.23
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
Read More
Media Coverage
|
Posted on 5.17.23
Nicole Paulk’s Siren Bio is building a gene therapy delivery vehicle against cancer
Read More
Media Coverage
|
Posted on 5.17.23
ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology
Read More
Media Coverage
|
Posted on 5.17.23
A new startup looks to turn the workhorse of gene therapy against cancer
Read More
Press Releases
|
Posted on 5.17.23
Siren Biotechnology Unveils Preclinical Data for Universal AAV Immuno-Gene Therapy for Cancer, a Novel Modality that Combines AAV Gene Therapy and Cytokine Immunotherapy
Read More
Press Releases
|
Posted on 5.17.23
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy for Cancer
Read More
1
…
3
4
5
6